Surgically implanted device that allows controlling diabetes and reducing obesity

Surgically implanted device that allows controlling diabetes and reducing obesity

Doctors at the hospital in Barcelona Bellvitge first appeal to a new type of surgery that allows reduction of obesity and diabetes control, agency EFE reported Monday.


The system consists of placing a device in the small intestine leaving the stomach by endoscopic intervention. The device creates an internal barrier between food intake and first part of the bowel wall, allowing food to get digested faster and less at the other end of the intestine, as if 'by-pass' gastric surgery.

Placing the device is outpatient anesthesia and does not require intervention takes less than half an hour, but the patient must remain in hospital under observation for one night.

This treatment is indicated in patients suffering from type 2 diabetes who do not respond positively traditional treatment. After a year when the patient may lose up to 20% of body weight, the device is extracted all about endoscopy.